Therefore, levels of the key factors of the AKT and ERK pathways in HCC cells were assessed, and then it was discovered that the sh-LINC01857 group expressed downregulated phosphorylation levels of AKT and ERK in HCC cells (all p<0.01) (Fig 6A). The gene discussed is AKT1; the disease is hepatocellular carcinoma.